GLUTEX Sanitizers from Dow Microbial Control have proven efficacy, with independent data showing positive results against many Influenza Type A Viruses such as Avian Influenza Virus strain H6N2 and the Highly Pathogenic Avian Influenza (HAPI) strain H5N1. GLUTEX products have been proven effective against more than 15 other avian and swine viruses including SARS-associated Coronavirus, Porcine Circovirus (PCV), Porcine Reproductive Respiratory Syndrome (PRRS), Newcastle Disease, Marek’s Disease, and Hog Cholera. Influenza A viruses change frequently and Dow Microbial Control is working with independent microbiological testing facilities to produce efficacy data for GLUTEX products against the H1N1 strain of Influenza.

Proven GLUTEX GS2 Sanitizer is available for sanitizing use. With broad efficacy against bacteria, viruses and fungi, GLUTEX Sanitizers are an important part of a comprehensive biosecurity program, by controlling microbial contamination in different environments.

For detailed instructions on the use of GLUTEX products, including use by spraying or fogging, consult the product label and technical information.

Glutaraldehyde has also been identified by the World Health Organization (WHO), as an effective sanitizer against the Avian Influenza virus. Glutaraldehyde-based GLUTEX products are also registered with the United States Environmental Protection Agency (EPA) and several countries around the world for a broad range of sanitizing applications, such as Gram-positive and Gram-negative bacteria, fungi and a variety of viruses pathogenic to animals.


®™*Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow.